Kim Nguyen, PharmD, discusses findings from her OPC abstract on cardiovascular toxicities and drug-drug interactions associated with BTK inhibitors, highlighting strategies for individualized treatment selection and patient monitoring.
Kim Nguyen, PharmD
Advertisement
Articles by Kim Nguyen, PharmD
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
2
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
3
ADA 2026: Diabetes Technology Innovations Expand Beyond Traditional CGM Use
4
Olezarsen Receives FDA Approval to Reduce Triglycerides, Risk of Acute Pancreatitis in Severe Hypertriglyceridemia
5